3
Shared Docs
3
Same-Page
6 / 3
Mentions
ns in past pay from Solomon's predecessor, Lloyd Blankfein and other former executives. The Washington Post
ess, Richard Gnodde will give up $31 million in pay this year. In addition, the bank will take back millions in past pay from Solomon's predecessor, Lloyd Blankfein and other former executives. The Washington Post (10/22, Bogage, 14.2M) says, "Prosecutors in the Eastern District of New York charged the bank with
Efficacy Standards For Vaccine. The Washington Post (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safe
ess, Richard Gnodde will give up $31 million in pay this year. In addition, the bank will take back millions in past pay from Solomon's predecessor, Lloyd Blankfein and other former executives. The Washington Post <https://vvww.washingtonpost.corn/business/2020/10/22/goldman-sachs-Imdb-record-fine/> (10/22, Boga
ns in past pay from Solomon's predecessor, Lloyd Blankfein and other former executives. The Washington Post
0/22/covid-vaccine-safety-effectiveness- guidelines/> (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safet
ns in past pay from Solomon's predecessor, Lloyd Blankfein and other former executives. The Washington Post
ss, Richard Gnodde will give up $31 million in pay this year. In addition, the bank will take back millions in past pay from Solomon's predecessor, Lloyd Blankfein and other former executives. The Washington Post (10/22, Bogage, 14.2M) says, "Prosecutors in the Eastern District of New York charged the bank wit
Efficacy Standards For Vaccine. The Washington Post (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safe
Entities connected to both Lloyd Blankfein and the Food and Drug Administration's

Jeffrey Epstein
PERSON
Donald Trump
PERSON
Prince Andrew
PERSON
George W. Bush
PERSON
Barack Obama
PERSON
Vladimir Putin
PERSON
Prince Charles
PERSON
Bill Clinton
PERSON
Stephen Hawking
PERSON
John F. Kennedy
PERSON
Virginia Giuffre
PERSON
Michael Cohen
PERSON
Goldman Sachs
ORGANIZATIONLeon Black
PERSON
Hillary Clinton
PERSON
Marc Rich
PERSON
Ghislaine Maxwell
PERSON
Bloomberg L.P.
ORGANIZATION
Harry Reid
PERSON
Julie K. Brown
PERSON